Ann: Trading Halt, page-766

Understandably a lack of emotional resilience exhibited by many holders today enabling the lightweight antagonist to play mind games, do not let them inside your head block it out and use the ignore function to your advantage. From my perspective Mesoblast is on track for a conditional approval and most likely collaborating with the FDA to ensure a seamless rollout. Do you really think Krause would of come on board if he believed Mesoblast was damaged goods with the FDA? Some very level headed contributors have emerged @ col69 and @Leapzig have been in my opinion level headed and insightful thank you.